-
VAXX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Vaxxinity (VAXX)
Company Profile
Quarter (USD) | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 5.04 mm | 5.04 mm | 5.04 mm | 5.04 mm | 5.04 mm | 5.04 mm |
Cash burn (monthly) | 4.19 mm | 2.46 mm | 3.88 mm | 4.86 mm | 3.95 mm | 4.77 mm |
Cash used (since last report) | 54.44 mm | 31.99 mm | 50.48 mm | 63.18 mm | 51.32 mm | 62.00 mm |
Cash remaining | -49.41 mm | -26.96 mm | -45.44 mm | -58.15 mm | -46.29 mm | -56.97 mm |
Runway (months of cash) | -11.8 | -11.0 | -11.7 | -12.0 | -11.7 | -11.9 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 53 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 4.99 mm |
Total shares | 171.20 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Prime Movers Lab Fund I | 113.30 mm | $0.00 |
United Biomedical | 57.88 mm | $0.00 |
Clarius | 20.00 k | $4.99 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Nov 23 | Sumita Ray | Employee Stock option Class A Common Stock | Grant | Acquire A | No | No | 1.17 | 425,000 | 497.25 k | 425,000 |
2 Oct 23 | Peter Powchik | Stock option Class A common stock | Grant | Acquire A | No | No | 1.27 | 159,744 | 202.87 k | 159,744 |
8 Sep 23 | Prime Movers Lab Fund I | Class A common stock | Sell | Dispose S | Yes | No | 1.67 | 10,349 | 17.28 k | 3,594,122 |
8 Sep 23 | Prime Movers Lab Fund I | Class A common stock | Sell | Dispose S | Yes | No | 1.67 | 4,217 | 7.04 k | 1,464,578 |
8 Sep 23 | Prime Movers Lab Fund I | Class A Common Stock | Sell | Dispose S | Yes | No | 1.67 | 2,395 | 4.00 k | 831,658 |
8 Sep 23 | Prime Movers Lab Fund I | Class A common stock | Sell | Dispose S | No | No | 1.67 | 25,089 | 41.90 k | 8,713,663 |
8 Sep 23 | Prime Movers Lab Fund I | Class A common stock | Sell | Dispose S | Yes | No | 1.67 | 5,911 | 9.87 k | 2,053,079 |
7 Sep 23 | Prime Movers Lab Fund I | Class A common stock | Sell | Dispose S | Yes | No | 1.7872 | 8,378 | 14.97 k | 3,604,471 |
7 Sep 23 | Prime Movers Lab Fund I | Class A common stock | Sell | Dispose S | Yes | No | 1.7872 | 3,413 | 6.10 k | 1,468,795 |
7 Sep 23 | Prime Movers Lab Fund I | Class A Common Stock | Sell | Dispose S | Yes | No | 1.7872 | 1,939 | 3.47 k | 834,053 |